Angiotensin-converting enzyme 2 decreased expression during kidney inflammatory diseases: implications to predisposing to COVID-19 kidney complications.

Garcia, Gabriela E; Truong, Luan D; Johnson, Richard J

Garcia, Gabriela E; Truong, Luan D; Johnson, Richard J.

Afiliación

Garcia GE; Department of Medicine, Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Electronic address: Gabriela.garcia@cuanschutz.edu.
Truong LD; Department of Pathology, Baylor College of Medicine, Houston, Texas, USA; Department of Pathology, The Methodist Hospital, Houston, Texas, USA.
Johnson RJ; Department of Medicine, Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Kidney Int ; 100(5): 1138-1140, 2021 11.

Article en En | MEDLINE | ID: mdl-34474076

Asunto(s)

COVID-19; Enfermedades Renales; Antagonistas de Receptores de Angiotensina; Enzima Convertidora de Angiotensina 2; COVID-19/enzimología; Humanos; Riñón/metabolismo; Peptidil-Dipeptidasa A/genética; Peptidil-Dipeptidasa A/metabolismo; Sistema Renina-Angiotensina; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Enfermedades Renales Límite: Humans Idioma: En Revista: Kidney Int Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google